Otomize® ear spray now available as a generic

Pharmacy teams should be aware that the brand Otomize^® ear spray has been discontinued and will no longer be available for community pharmacies to order once existing stock is exhausted.

The manufacturer Ennogen Healthcare International Limited has instead launched a generic equivalent  version as Dexamethasone/ Neomycin sulfate/ Acetic acid 0.1%w/w / 0.5%w/w / 2%w/w Ear Spray. The generic is now readily available to order from wholesalers.

Please note, where a prescriber has issued a prescription for Otomize® ear spray and the brand is unavailable to order, pharmacy teams are advised to contact the prescriber and request a replacement prescription for the generic Dexamethasone/ Neomycin sulfate/ Acetic acid 0.1%w/w / 0.5%w/w / 2%w/w Ear Spray.

Furthermore,  pharmacy teams are advised to check, when ordering, that the correct product is selected on systems i.e. Dexamethasone/ Neomycin sulfate/ Acetic acid 0.1%w/w / 0.5%w/w / 2%w/w Ear Spray instead of Otomize^® ear spray.

Issues with product being prescribable within GP EPS systems: Community Pharmacy England recognises that prescribers may not find the generic product available to select in their clinical system. If EPS systems aren’t aligned with the latest changes to NHS Dictionary of Medicines and Devices (dm+d), then medicinal products which have had changes to their dm+d entry may not be EPS-prescribable or be able to be processed correctly— sometimes meaning a paper prescription is needed. IT suppliers should align with the latest weekly dm+d update at the start of each month to ensure pharmacies and prescribers have the right medicine and Drug Tariff information in their systems at the right time. EPS users with questions can check with their IT supplier.

Should you require any further information please contact Ennogen on 01322 629220 or email info@ennogen.com  if you have any questions relating to the generic medicine listed above.